Retatrutide

Retatrutide is a next-generation triple-agonist peptide (GLP-3) that activates GLP-1, GIP, and glucagon receptors, delivering powerful effects on fat loss, appetite control, and metabolic health. Human data and real-world use show significant reductions in body weight and body fat, alongside improvements in insulin sensitivity, glucose regulation, energy expenditure, and lipid profiles. Its multi-pathway action makes it one of the most advanced compounds available for comprehensive metabolic optimization and weight-management support.

Common dosing:
• 1–2 mg per week (beginner / conservative use)
• 2–4 mg per week (moderate use)
• Up to 6 mg per week (advanced users)
Typically administered as 1–2 injections per week, with gradual titration to minimize side effects.